The utility of Pax-2 as an immunohistochemical marker for renal cell carcinoma in cytopathology

Diagnostic Cytopathology

Volumn 36, Issue 7, 2008, Pages 473-477

  Gokden, Neriman ^a   Kemp, Susan A ^a   Gokden, Murat ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Cytopathology; Fine needle aspiration biopsy; Immunohistochemistry; Pax 2; Renal cell carcinoma

Indexed keywords

TRANSCRIPTION FACTOR PAX2;

ARTICLE; ASPIRATION BIOPSY; BODY FLUID; CANCER DIAGNOSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; CYTOPATHOLOGY; ENDOMETRIUM CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LYMPHOMA; MELANOMA; MESENCHYMOMA; NEUROBLASTOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TISSUE SECTION;

CARCINOMA, RENAL CELL; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; PAX2 TRANSCRIPTION FACTOR; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 46049091338     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.20842     Document Type: Article

References (24)

1. Mansouri A, Hallonet M, Gruss P. Pax genes and their roles in cell differentiation and development. Curr Opin Cell Biol 1996;8:851-857.
2. Eccles MR. The role of Pax-2 in normal and abnormal development of the urinary tract. Pediatr Nephrol 1998;12:712-720.
3. Dressler GR, Deutsch U, Chowdhury K, Nornes HO, Gruss P. Pax2, a new murine paired-box containing gene and its expression in the developing excretory system. Development 1990;109:787-795.
4. Eccles MR, Wallis LJ, Fidler AE, Spurr NK, Goodfellow PJ, Reeve AE. Expression of the Pax2 gene in human fetal kidney and Wilms' tumor. Cell Growth Differ 1992;3:279-289.
5. Oefelein M, Grapey D, Schaeffer T, Chin-Chance C, Bushman W. Pax-2: A developmental gene constitutively expressed in the mouse epididymis and ductus deferense. J Urol 1996;156:1204-1207.
6. Dahl E, Koseki H, Balling R. Pax genes and organogenesis. Bioasseys 1997;9:755-765.
7. Gnarra JR, Dressler GR. Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides. Cancer Res 1995;55:4092-4098.
8. Daniel L, Lechevallier E, Giorgi R, et al. Pax-2 expression in adult renal tumors. Human Pathol 2001;32:282-287.
9. Mazal PR, Stichenwirth M, Koller A, Blach S, Haitel A, Susani M. Expression of aquaporins and Pax-2 compared to CD10 and cytokeratin 7 in renal neoplasms: A tissue microarray study. Modern Pathol 2005;18:535-540.
10. Memeo L, Jhang J, Assaad AM, et al. Immunohistochemical analysis for cytokeratin 7. KIT, and Pax2: Value in the differential diagnosis of chromophobe cell carcinoma Am J Clin Pathol 2007;127:225-229.
11. Bales C. Laboratory techniques. In: Koss LG and Melamed MR, editors. Koss' diagnostic cytology and its histopathologic bases, Vol. 2. 5th ed. Philadelphia, PA: Lippincott, Williams and Wilkins; 2006, p 1590.
12. Al Nazer M, Mourad WA. Succesful grading of renal cell carcinoma in fine needle aspirates. Diagn Cytopathol 2000;22:223-226.
13. Helm CW, Burwood RJ, Harrison NW, Melcher DH. Aspiration cytology of solid renal tumors. Br J Urol 1983;55:249-253.
14. Pilotti S, Rilke F, Alasio L, Garbagnati F. The role of fine needle aspiration in the assessment of renal masses. Acta Cytol 1988;32:1-10.
15. Bradham RR, Wannamaker CC, Prat-Thomas HR. Renal cell carcinoma metastases 25 years after nephrectomy. JAMA 1973;223:921-922.
16. Saleh H, Masood S, Wynn G, Assaf N. Unsuspected metastatic renal cell carcinoma diagnosed by fine needle aspiration biopsy. Acta Cytol 1994;38:554-561.
17. Wahner-Roedler DL, Sebo TJ. Renal cell carcinoma: Diagnosis based on metastatic manifestations. Mayo Clin Proc 1997;72:935-941.
18. Gokden N, Mukunyadzi P, James JD, Gokden M. Diagnostic utility of renal cell carcinoma marker in cytopathology. Appl Immunohistochem Mol Morphol 2003;11:116-119.
19. Igarashi T, Ueda T, Suzuki H, et al. Aberrant expression of Pax-2 RNA in renal cell carcinoma tissue of the affected kidney. Internat J Urol 2001;8:60-64.
20. Simsir A, Chhieng D, Wei XJ, Yee H, Waisman J, Cangiarella J. Utility of CD10 and RCCma in the diagnosis of metastatic conventional renal cell adenocarcinoma by fine-needle aspiration biopsy. Diagn Cytopathol 2005;33:3-7.
21. Torres M, Gomez-Pardo E, Dressler GR, Gruss P. Pax-2 controls multiple steps of urogenital development. Development 1995;121:4057-4065.
22. Bartol FF, Wiley AA, Bagnell CA. Uterine development and endometrial programming. Soc Reprod Fertil Suppl 2006;62:113-130.
23. Wu H, Chen Y, Liang J, et al. Hypomethylation-linked activation of Pax2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature 2005;438:981-987.
24. Tong GX, Chiriboga L, Hamele-Bena D, Borczuk AC. Expression of Pax-2 in papillary serous carcinoma of the ovary: Immunohistochemical evidence of fallopian tube or secondary Mullerian system origin? Mod Pathol 2007;20:856-863.